Your browser doesn't support javascript.
loading
Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175.
Chitnis, Chetan E; Mukherjee, Paushali; Mehta, Shantanu; Yazdani, Syed Shams; Dhawan, Shikha; Shakri, Ahmad Rushdi; Bhardwaj, Rukmini; Bharadwaj, Rukmini; Gupta, Puneet Kumar; Hans, Dhiraj; Mazumdar, Suman; Singh, Bijender; Kumar, Sanjeev; Pandey, Gaurav; Parulekar, Varsha; Imbault, Nathalie; Shivyogi, Preethi; Godbole, Girish; Mohan, Krishna; Leroy, Odile; Singh, Kavita; Chauhan, Virander S.
Afiliación
  • Chitnis CE; International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.
  • Mukherjee P; International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.
  • Mehta S; Malaria Vaccine Development Program (MVDP), New Delhi, India.
  • Yazdani SS; International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.
  • Dhawan S; International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.
  • Shakri AR; International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.
  • Bharadwaj R; International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.
  • Gupta PK; International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.
  • Hans D; International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.
  • Mazumdar S; International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.
  • Singh B; International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.
  • Kumar S; International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.
  • Pandey G; Malaria Vaccine Development Program (MVDP), New Delhi, India.
  • Parulekar V; Diagnosearch Laboratory Services, Mumbai, India.
  • Imbault N; European Vaccine Initiative (EVI), Heidelberg, Germany.
  • Shivyogi P; Lotus Laboratories, Bangalore, India.
  • Godbole G; Lotus Laboratories, Bangalore, India.
  • Mohan K; Bharat Biotech International Ltd. (BBIL), Hyderabad, India.
  • Leroy O; European Vaccine Initiative (EVI), Heidelberg, Germany.
  • Singh K; Malaria Vaccine Development Program (MVDP), New Delhi, India.
  • Chauhan VS; International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.
PLoS One ; 10(4): e0117820, 2015.
Article en En | MEDLINE | ID: mdl-25927360
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Plasmodium falciparum / Proteínas Protozoarias / Malaria Falciparum / Vacunas contra la Malaria / Proteína 1 de Superficie de Merozoito / Antígenos de Protozoos Tipo de estudio: Clinical_trials / Guideline Límite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2015 Tipo del documento: Article País de afiliación: India Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Plasmodium falciparum / Proteínas Protozoarias / Malaria Falciparum / Vacunas contra la Malaria / Proteína 1 de Superficie de Merozoito / Antígenos de Protozoos Tipo de estudio: Clinical_trials / Guideline Límite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2015 Tipo del documento: Article País de afiliación: India Pais de publicación: Estados Unidos